Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are biologically female
- People aged 50 years or older
- People with a confirmed diagnosis of a specific type of breast cancer called infiltrating ductal carcinoma, where the cancer is hormone receptor positive (ER/PR+) and HER2 negative, and graded as Grade I, II, or III
- People whose tumor is in one location, in one breast only, and is 3 cm or smaller in size
- People whose tumor is located at least 2 cm away from the skin and nearby structures
- People with a Zubrod Performance Status of 0, 1, or 2 — this is a rating used by doctors to describe how much a person's daily activities are affected by their condition (confirm with trial site)
- People with no swollen or enlarged lymph nodes that can be felt
- People who are able and willing to sign a written consent form
Who may not be able to join:
- People who are pregnant or breastfeeding
- People who have received chemotherapy before surgery (called neoadjuvant chemotherapy)
- People who have an irregular heart rhythm (cardiac arrhythmia)
- People who have an active implanted medical device, such as a pacemaker, defibrillator, or any other electronic implant
- People who currently have or have previously had breast implants
- People whose breast cancer is present in more than one area of the breast, or in both breasts
- People with a widespread pattern of tiny calcium deposits in the breast, known as diffuse microcalcifications
- People who are already taking part in another clinical study that involves treatments or tests that could affect the results of this trial
- People who, in the opinion of the trial investigator, have a condition or situation that could put them at significant risk, affect the study results, or interfere with their ability to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: V. Suzanne Klimberg, MD, PhD, MSCHT, MAMSE, FACS
Phone: 833-920-4660
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To assess the safety of SIRA-1000 by summarizing the occurrence of Adverse Events.; Healing Process assessed by BREAST-Q Questionnaire
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.